跳至主要内容
临床试验/IRCT20110425006280N12
IRCT20110425006280N12招募中未知

Evaluation of Hemoperfusion effect in treatment of patients with COVID-19 hospitalized in intensive care unit, Randomized clinical trial

Vice President of Research Guilan university of medical sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 no limit(—)
性别
All

入选标准

  • Patients with a clinical diagnosis of Covid-19 including respiratory distress with a rate of more than 30 per minute and heart rate more than 125 beats per minute and shortness of breath and oxygen saturation less than 90%, despite receiving oxygen with a positive PCR test and Radiographs in CT SCANING or Chest X Ray, admitted to the intensive care unit.
  • Uncontrollable fevers like T> 39 C.
  • An laboratory evidence of increased inflammatory factors
  • Patients 12 years and older
  • Evidence of severe hemodynamic disturbance using moderate doses of norepinephrine or using a second dose of vasopressor
  • Involvement of more than two vital organs (lungs, kidneys, liver, and heart)

排除标准

  • Thrombocytopenia (Plt =20,000)
  • Acute crisis due to sickle cell anemia
  • Evidence of resin sensitivity

研究者

发起方
Vice President of Research Guilan university of medical sciences

相似试验